Skip to main content
Clinical Trials/NCT03456557
NCT03456557
Completed
Not Applicable

The Use of Perfusion CT Derived Parameters as Early Acute Pancreatitis Severity Biomarker Compared to Clinico Biological Score

Poitiers University Hospital1 site in 1 country15 target enrollmentMarch 7, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Pancreatitis
Sponsor
Poitiers University Hospital
Enrollment
15
Locations
1
Primary Endpoint
Relation between CT perfusion calculated k-trans and clinicobiological SIRS score in early phase of acute pancreatitis.
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The investigators to establish whether early microvascular permeability parameter evaluated by perfusion-CT could be good biomarkers for severity in acute pancreatitis.

Therefore the investigators want to compare 48 hours-clinico-biological systemic inflammatory response syndrome score to initial microvascular permeability parameters ( ktrans - capillary membrane permeability factor- and pancreatic blood flow ) calculated by OLEA software using inclusion perfusion CT.

Registry
clinicaltrials.gov
Start Date
March 7, 2018
End Date
December 9, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient with acute pancreatitis (based on the Atlanta definition).

Exclusion Criteria

  • Patient under 18 yearras old
  • Contraindication of injection of iodinated contrast medium
  • Pregnancy

Outcomes

Primary Outcomes

Relation between CT perfusion calculated k-trans and clinicobiological SIRS score in early phase of acute pancreatitis.

Time Frame: admission day

Study Sites (1)

Loading locations...

Similar Trials